Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-36999
Bioorg Med Chem Lett 2007 Sep 01;1717:4855-60. doi: 10.1016/j.bmcl.2007.06.047.
Show Gene links Show Anatomy links

Synthesis of desformylflustrabromine and its evaluation as an alpha4beta2 and alpha7 nACh receptor modulator.

Kim JS , Padnya A , Weltzin M , Edmonds BW , Schulte MK , Glennon RA .


???displayArticle.abstract???
Desformylflustrabromine (dFBr; 1) and desformylflustrabromine-B (dFBr-B; 2) have been previously isolated from natural sources, and the former has been demonstrated to be a novel and selective positive allosteric modulator of alpha4beta2 nicotinic acetylcholine (nACh) receptors. The present study describes the synthesis of water-soluble salts of 1 and 2, and confirms and further investigates the actions of 1 and 2 using two-electrode voltage clamp recordings.

???displayArticle.pubmedLink??? 17604168
???displayArticle.pmcLink??? PMC3633077
???displayArticle.link??? Bioorg Med Chem Lett
???displayArticle.grants??? [+]


References [+] :
Albuquerque, Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease. 2001, Pubmed